These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 30082471)

  • 1. Hexosamine Biosynthetic Pathway Inhibition Leads to AML Cell Differentiation and Cell Death.
    Asthana A; Ramakrishnan P; Vicioso Y; Zhang K; Parameswaran R
    Mol Cancer Ther; 2018 Oct; 17(10):2226-2237. PubMed ID: 30082471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single cell and bulk RNA expression analyses identify enhanced hexosamine biosynthetic pathway and O-GlcNAcylation in acute myeloid leukemia blasts and stem cells.
    Schauner R; Cress J; Hong C; Wald D; Ramakrishnan P
    Front Immunol; 2024; 15():1327405. PubMed ID: 38601153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing O-GlcNAc transferase-mediated protein O-GlcNAcylation.
    Hu J; Gao Q; Yang Y; Xia J; Zhang W; Chen Y; Zhou Z; Chang L; Hu Y; Zhou H; Liang L; Li X; Long Q; Wang K; Huang A; Tang N
    Theranostics; 2021; 11(2):805-823. PubMed ID: 33391506
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibiting the Hexosamine Biosynthetic Pathway Lowers O-GlcNAcylation Levels and Sensitizes Cancer to Environmental Stress.
    Walter LA; Lin YH; Halbrook CJ; Chuh KN; He L; Pedowitz NJ; Batt AR; Brennan CK; Stiles BL; Lyssiotis CA; Pratt MR
    Biochemistry; 2020 Sep; 59(34):3169-3179. PubMed ID: 31625393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial Mesenchymal Transition Induces Aberrant Glycosylation through Hexosamine Biosynthetic Pathway Activation.
    Lucena MC; Carvalho-Cruz P; Donadio JL; Oliveira IA; de Queiroz RM; Marinho-Carvalho MM; Sola-Penna M; de Paula IF; Gondim KC; McComb ME; Costello CE; Whelan SA; Todeschini AR; Dias WB
    J Biol Chem; 2016 Jun; 291(25):12917-29. PubMed ID: 27129262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hexosamine biosynthetic pathway and cancer: Current knowledge and future therapeutic strategies.
    Lam C; Low JY; Tran PT; Wang H
    Cancer Lett; 2021 Apr; 503():11-18. PubMed ID: 33484754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the hexosamine biosynthetic pathway and O-linked N-acetylglucosamine cycling for therapeutic and imaging capabilities in diffuse large B-cell lymphoma.
    Pham LV; Bryant JL; Mendez R; Chen J; Tamayo AT; Xu-Monette ZY; Young KH; Manyam GC; Yang D; Medeiros LJ; Ford RJ
    Oncotarget; 2016 Dec; 7(49):80599-80611. PubMed ID: 27716624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. O-GlcNAcylation inhibition redirects the response of colon cancer cells to chemotherapy from senescence to apoptosis.
    Loison I; Pioger A; Paget S; Metatla I; ; Vincent A; Abbadie C; Dehennaut V
    Cell Death Dis; 2024 Oct; 15(10):762. PubMed ID: 39426963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. O-GlcNAc elevation through activation of the hexosamine biosynthetic pathway enhances cancer cell chemoresistance.
    Liu Y; Cao Y; Pan X; Shi M; Wu Q; Huang T; Jiang H; Li W; Zhang J
    Cell Death Dis; 2018 May; 9(5):485. PubMed ID: 29706631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hexosamine Biosynthetic Pathway-Derived O-GlcNAcylation Is Critical for RANKL-Mediated Osteoclast Differentiation.
    Kim MJ; Kim HS; Lee S; Min KY; Choi WS; You JS
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hexosamines, insulin resistance, and the complications of diabetes: current status.
    Buse MG
    Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E1-E8. PubMed ID: 16339923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First characterization of glucose flux through the hexosamine biosynthesis pathway (HBP) in
    Olson AK; Bouchard B; Zhu WZ; Chatham JC; Des Rosiers C
    J Biol Chem; 2020 Feb; 295(7):2018-2033. PubMed ID: 31915250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Hexosamine Biosynthetic Pathway as a Therapeutic Target after Cartilage Trauma: Modification of Chondrocyte Survival and Metabolism by Glucosamine Derivatives and PUGNAc in an Ex Vivo Model.
    Riegger J; Baumert J; Zaucke F; Brenner RE
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Glycogen Synthase Kinase-3 Inhibitor Optimized for Acute Myeloid Leukemia Differentiation Activity.
    Hu S; Ueda M; Stetson L; Ignatz-Hoover J; Moreton S; Chakrabarti A; Xia Z; Karan G; de Lima M; Agrawal MK; Wald DN
    Mol Cancer Ther; 2016 Jul; 15(7):1485-1494. PubMed ID: 27196775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. O-GlcNAcylation Enhances Double-Strand Break Repair, Promotes Cancer Cell Proliferation, and Prevents Therapy-Induced Senescence in Irradiated Tumors.
    Efimova EV; Appelbe OK; Ricco N; Lee SS; Liu Y; Wolfgeher DJ; Collins TN; Flor AC; Ramamurthy A; Warrington S; Bindokas VP; Kron SJ
    Mol Cancer Res; 2019 Jun; 17(6):1338-1350. PubMed ID: 30885991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HBP/O-GlcNAcylation Metabolic Axis Regulates Bone Resorption Outcome.
    Taira TM; Ramos-Junior ES; Melo PH; Costa-Silva CC; Alteen MG; Vocadlo DJ; Dias WB; Cunha FQ; Alves-Filho JC; Søe K; Fukada SY
    J Dent Res; 2023 Apr; 102(4):440-449. PubMed ID: 36749069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.
    Sodi VL; Khaku S; Krutilina R; Schwab LP; Vocadlo DJ; Seagroves TN; Reginato MJ
    Mol Cancer Res; 2015 May; 13(5):923-33. PubMed ID: 25636967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bittersweet tumor development and progression: Emerging roles of epithelial plasticity glycosylations.
    Phillips RM; Lam C; Wang H; Tran PT
    Adv Cancer Res; 2019; 142():23-62. PubMed ID: 30885363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of NDPK-B in Glucose Metabolism-Mediated Endothelial Damage via Activation of the Hexosamine Biosynthesis Pathway and Suppression of O-GlcNAcase Activity.
    Chatterjee A; Eshwaran R; Poschet G; Lomada S; Halawa M; Wilhelm K; Schmidt M; Hammes HP; Wieland T; Feng Y
    Cells; 2020 Oct; 9(10):. PubMed ID: 33086728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mTORC2 modulates the amplitude and duration of GFAT1 Ser-243 phosphorylation to maintain flux through the hexosamine pathway during starvation.
    Moloughney JG; Vega-Cotto NM; Liu S; Patel C; Kim PK; Wu CC; Albaciete D; Magaway C; Chang A; Rajput S; Su X; Werlen G; Jacinto E
    J Biol Chem; 2018 Oct; 293(42):16464-16478. PubMed ID: 30201609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.